Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Changing Resistance Mechanisms in Rebiopsies of ALK-Positive NSCLC During Multiple Lines of Therapy: ALK/BRAF-Mutations Followed By EMT: P3.08-18

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Locally Advanced Lung Cancer Radiotherapy in Deep Inspiration Breath Hold: Dosimetric Benefits from a Prospective Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Behandling af tymom og thymuskarcinom

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. EP1.08-07 Correlation Between Genetic Profiling and Response in Danish ALK-Positive NSCLC Patients Treated with Crizotinib

    Research output: Contribution to conferencePosterResearchpeer-review

View graph of relations
The relationship between excision repair cross-complementation group 1 (ERCC1) expression and outcome, in patients with malignant pleural mesothelioma (MPM), treated with cisplatin/vinorelbine combination-therapy, was retrospectively evaluated in a patient population from a previously published phase II clinical trial.
Original languageEnglish
JournalJournal of Thoracic Oncology
Volume7
Issue number1
Pages (from-to)249-56
Number of pages8
ISSN1556-0864
DOIs
Publication statusPublished - 2012

ID: 33255538